Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Lillys phase 3 TRIUMPH-1 results also evaluated outcomes over 80 weeks, with a subgroup continuing to 104 weeks
Weight Loss: Wegovy, the weight-loss-specific brand of Semaglutide, is approved for weight management in overweight or obese adults
Slight variation is normal
The legal landscape has tightened significantly
The Phase 1b trial was published in The Lancet in 2022, confirming the compound's half-life supported weekly administration
This means utilization and gross spending totals can vary depending on when the data is downloaded, and totals may not match other outside sources or prior KFF analysis for this reason
US$ 25.81
US$ 28.01
US$ 25.76
US$ 29.73
US$ 29.16
US$ 28.09
US$ 24.25
US$ 19.98
